학술논문
Adding Mirabegron to Solifenacin to Treat Overactive Bladder Has Little Impact on Postvoid Residual Volume or Urinary Retention Risk
Document Type
Article
Author
Source
In: Urology . (Urology, June 2017, 104:1-4)
Subject
Language
English
ISSN
15279995
00904295
00904295